Camilla Chong, MD, Chief Medical Officer of InflaRx, commented: “We are pleased to have started our Phase 2a trial for INF904 with the first patient dosed at one of our U.S. sites, and I am very proud ...
Learn More Avextra is one of Europe’s leading vertically integrated medical cannabis and research operators focused on developing and producing regulatory-approved medicines. Founded in 2019 and based ...